ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 3002

Does Morbid Obesity Negatively Affect Patient Reported Outcomes Following Total Knee Arthroplasty?

Jamie E. Collins1, Heidi Y. Yang2, Ilana M. Usiskin3, Jeffrey N. Katz4 and Elena Losina5, 1Orthopaedic and Arthritis Center for Outcomes Research, Department of Orthopedic Surgery, Brigham & Women's Hospital, Boston, MA, 2Orthopaedic and Arthritis Center for Outcomes Research, Brigham & Women's Hospital, Boston, MA, 3Orthopaedic and Arthritis Center for Outcomes Research, Brigham and Women's Hospital, Boston, MA, 4Orthopaedics, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 5Orthopaedics, Brigham & Women's Hospital, Boston, MA

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: obesity and outcomes, Total Knee Arthroplasty (TKA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 15, 2016

Title: Orthopedics, Low Back Pain and Rehabilitation

Session Type: ACR Concurrent Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose: Utilization of total knee arthroplasty (TKA) continues to grow. Recent literature has questioned the appropriateness of TKA for patients that are morbidly obese, citing the high risk of complications. Data on the impact of obesity on patient-reported outcomes following TKA remain sparse. We assessed the extent to which obesity level affects patient-reported outcomes in pain, function, and satisfaction with surgery following TKA.

Methods: We followed a cohort of TKA recipients 40 years or older with a primary diagnosis of osteoarthritis scheduled for TKA at four tertiary medical centers. We stratified patients into 5 groups using the World Health Organization categories for obesity based on body mass index (BMI). We assessed whether obesity category is associated with post-operative pain and function evaluated at 24 months, as well as baseline to 24 month changes in pain and function. We used a piecewise linear model with a knot at 3 months to determine covariates associated with early and late TKA recovery. Multivariable models adjusted for age, sex, race, diabetes, musculoskeletal functional limitation index, medication use and study site.

Results: 691 patients were enrolled across 4 centers, with 633 providing baseline BMI information and outcomes at one or more follow-ups. At baseline 19% were normal weight (BMI < 25), 32% were overweight (25 ≤ BMI <30), 27% were obese (30 ≤ BMI <35), 12% were morbidly obese (35 ≤ BMI <40) and 9% were severely obese (BMI ≥40). There were differences in baseline characteristics between BMI groups. Heavier subjects tended to be younger, were more likely to be female, non-White, and have diabetes. Study participants with higher BMI had worse preoperative WOMAC Pain and Function, with mean pre-operative pain score ranging from 34 in normal weight participants to 50 in severely obese participants, and mean pre-operative function score ranging from 35 in normal weight participants to 51 in severely obese participants. Patients in all BMI groups showed substantial improvement in pain (Figure). At 24 month follow-up there was no significant difference in WOMAC Pain between the BMI Groups. The results suggested that more obese patients had a steeper recovery slope from baseline to 3 months, and no difference in slope by BMI group between 3 and 24 months. Results were similar for WOMAC Function. All groups reported high satisfaction with the results of surgery, with 75% very satisfied at month 6 and 80% very satisfied at month 24. 

Conclusion: Despite worse pain and functional status preoperatively, subjects in all BMI groups achieved similar pain relief and functional improvements following TKA. From the standpoint of patient reported outcomes, TKA is highly effective in obese patients. Figure. Adjusted Mean WOMAC Pain by BMI Group and Timepoint The SGPlot Procedure


Disclosure: J. E. Collins, None; H. Y. Yang, None; I. M. Usiskin, None; J. N. Katz, None; E. Losina, None.

To cite this abstract in AMA style:

Collins JE, Yang HY, Usiskin IM, Katz JN, Losina E. Does Morbid Obesity Negatively Affect Patient Reported Outcomes Following Total Knee Arthroplasty? [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/does-morbid-obesity-negatively-affect-patient-reported-outcomes-following-total-knee-arthroplasty/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/does-morbid-obesity-negatively-affect-patient-reported-outcomes-following-total-knee-arthroplasty/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology